288 related articles for article (PubMed ID: 33559307)
1. Prognostic factors in patients with complete response of the tumour (ypT0) after neoadjuvant chemoradiotherapy and radical resection of rectal cancer.
Zhang H; Sun G; Zheng K; Lou Z; Gao XH; Meng RG; Furnée EJB; Zhang W
ANZ J Surg; 2021 Apr; 91(4):E190-E195. PubMed ID: 33559307
[TBL] [Abstract][Full Text] [Related]
2. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
3. Prognostic significance of carcinoembryonic antigen combined with carbohydrate antigen 19-9 following neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Zheng Z; Wang X; Lu X; Huang Y; Chi P
Colorectal Dis; 2021 Sep; 23(9):2320-2330. PubMed ID: 33900006
[TBL] [Abstract][Full Text] [Related]
4. Downstaged ypT0-2N0 rectal cancer after neoadjuvant chemoradiation therapy may not need adjuvant chemotherapy: a retrospective cohort study.
Liao YT; Lin YL; Huang J; Hung JS; Lin BR
Int J Colorectal Dis; 2021 Mar; 36(3):509-516. PubMed ID: 33128083
[TBL] [Abstract][Full Text] [Related]
5. Nonmetastatic ypt0 rectal cancer after neoadjuvant treatment and total mesorectal excision: Lessons from a retrospective multicentric cohort of 383 patients.
Collard MK; Rullier E; Panis Y; Manceau G; Benoist S; Tuech JJ; Alves A; Laforest A; Mege D; Cazelles A; Beyer-Berjot L; Christou N; Cotte E; Lakkis Z; O'Connell L; Parc Y; Piessen G; Lefevre JH;
Surgery; 2022 May; 171(5):1193-1199. PubMed ID: 35078629
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of the treatment response of regional lymph nodes and the refinement of the current TNM staging system in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
Cui J; Zhang L; Yang L; Zhu YL; Fang H; Chen B; Ning Y; Zhang HZ
Cancer Med; 2020 Dec; 9(24):9373-9384. PubMed ID: 33079470
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.
Park IJ; You YN; Skibber JM; Rodriguez-Bigas MA; Feig B; Nguyen S; Hu CY; Chang GJ
Dis Colon Rectum; 2013 Feb; 56(2):135-41. PubMed ID: 23303140
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological and prognostic features of young onset patients with middle-low rectal cancer received neoadjuvant chemoradiotherapy].
Zhang QQ; Wu YL; Li DD; Shen SH; Fang H; Zhu YL; Zhang HZ
Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):574-580. PubMed ID: 34034478
[No Abstract] [Full Text] [Related]
9. Prognostic Implication of Negative Lymph Node Count in ypN+ Rectal Cancer after Neoadjuvant Chemoradiotherapy and Construction of a Prediction Nomogram.
Sun Y; Zhang Y; Huang Z; Chi P
J Gastrointest Surg; 2019 May; 23(5):1006-1014. PubMed ID: 30187336
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response.
Belluco C; Forlin M; Olivieri M; Cannizzaro R; Canzonieri V; Buonadonna A; Bidoli E; Matrone F; Bertola G; De Paoli A
Ann Surg Oncol; 2016 Dec; 23(13):4302-4309. PubMed ID: 27489059
[TBL] [Abstract][Full Text] [Related]
11. Rectal cancer patients with downstaging after neoadjuvant chemoradiotherapy and radical resection do not benefit from adjuvant chemotherapy.
Zhang H; Huang Y; Sun G; Zheng K; Lou Z; Gao XH; Hao LQ; Liu LJ; Meng RG; Zhang W
Ann Transl Med; 2020 Jun; 8(12):743. PubMed ID: 32647668
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological factors predict residual lymph node metastasis in locally advanced rectal cancer with ypT0-2 after neoadjuvant chemoradiotherapy.
Cui Y; Song M; Tie J; Li S; Wang H; Zhang Y; Geng J; Liu Z; Teng H; Sui X; Zhu X; Cai Y; Li Y; Wang W
J Cancer Res Clin Oncol; 2024 Apr; 150(4):176. PubMed ID: 38575793
[TBL] [Abstract][Full Text] [Related]
13. Inferior mesenteric artery lymph node metastasis in rectal cancer treated with neoadjuvant chemoradiotherapy: Incidence, prediction and prognostic impact.
Sun Y; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Wang X
Eur J Surg Oncol; 2017 Jan; 43(1):85-91. PubMed ID: 27717528
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Effects of Clinicopathological Features on Rectal Cancer Patients undergoing Neoadjuvant Chemoradiotherapy.
Arslan A; Akay E; Turk G; Eren SK
J Coll Physicians Surg Pak; 2021 Apr; 31(4):422-428. PubMed ID: 33866728
[TBL] [Abstract][Full Text] [Related]
15. Lymph Node Regression to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: Prognostic Implication and a Predictive Model.
Sun Y; Wu X; Lin H; Lu X; Huang Y; Chi P
J Gastrointest Surg; 2021 Apr; 25(4):1019-1028. PubMed ID: 32219686
[TBL] [Abstract][Full Text] [Related]
16. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
[TBL] [Abstract][Full Text] [Related]
17. Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
Zeng WG; Zhou ZX; Wang Z; Liang JW; Hou HR; Zhou HT; Zhang XM; Hu JJ
Asian Pac J Cancer Prev; 2014; 15(13):5365-9. PubMed ID: 25041003
[TBL] [Abstract][Full Text] [Related]
18. MRI-based parameters and clinical risk factors to predict lymph node metastasis in patients with ypT0 rectal cancer after neoadjuvant chemoradiotherapy.
Wang Y; Wang X; Huang S; Chen J; Huang Y
ANZ J Surg; 2024 Jun; 94(6):1127-1132. PubMed ID: 38251776
[TBL] [Abstract][Full Text] [Related]
19. Lymph node regression after neoadjuvant chemoradiotherapy in rectal cancer.
Ozturk SK; Martinez CG; Mens D; Verhoef C; Tosetto M; Sheahan K; de Wilt JHW; Hospers GAP; van de Velde CJH; Marijnen CAM; van der Post RS; Nagtegaal ID
Histopathology; 2024 May; 84(6):935-946. PubMed ID: 38192084
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma.
Kohl VKB; Weber K; Brunner M; Geppert CI; Fietkau R; Grützmann R; Semrau S; Merkel S
Int J Colorectal Dis; 2022 Jun; 37(6):1355-1365. PubMed ID: 35545701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
